The DOI matches its Crossref record; 218 of the 220 references it cites were found in a registry or an index.
Immune attack: the role of inflammation in Alzheimer disease
Abstract
The past two decades of research into the pathogenesis of Alzheimer disease (AD) have been driven largely by the amyloid hypothesis; the neuroinflammation that is associated with AD has been assumed to be merely a response to pathophysiological events. However, new data from preclinical and clinical studies have established that immune system-mediated actions in fact contribute to and drive AD pathogenesis. These insights have suggested both novel and well-defined potential therapeutic targets for AD, including microglia and several cytokines. In addition, as inflammation in AD primarily concerns the innate immune system - unlike in 'typical' neuroinflammatory diseases such as multiple sclerosis and encephalitides - the concept of neuroinflammation in AD may need refinement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In brain tissue from human AD patients, microglia display the morphology (Heppner et al., 2015) and gene expression profile (Gjoneska et al., 2015; Mathys et al., 2019) characteristic of an activated cell state and cluster around β-amyloid plaques.”
From A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation (2023) · cites this paper as Heppner et al., 2015
In the citing paper
“Immune molecules like IL-1β, IL-6 and CCL2 are produced by brain endothelial cells against Aβ plaque [18].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [18]
In the citing paper
“glial activation is an indication of pro-inflammatory changes that is commonly found in AD brains”
From ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease (2017) · cites this paper as [98]
In the citing paper
“In AD brains, microglia surrounding amyloid plaques display activated amoeboid morphologies with enlarged soma and retracted processes, indicating microglial response to protein accumulation or increased inflammatory mediators [41, 46-48].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [48]
In the citing paper
“indicating microglial response to protein accumulation or increased inflammatory mediators [41, 46-48].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [48]
Citations
Cites
1 retracted
Larson, M. E., Sherman, M. A., Amar, F., Nuvolone, M., Schneider, J. A., Bennett, D. A., Aguzzi, A., & Lesné, S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1858-12.2012 · Cited by 290
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Mosmann, T. R., Cherwinski, H. M., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,553
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Flagged first, then by citations
2 of the 220 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,003
Ma, C., Lin, M., Gao, J., Xu, S., Huang, L., Zhu, J., Huang, J., Tao, J., & Chen, L. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-02069-6 · Cited by 44
Prostaglandin J2: a potential target for halting inflammation‐induced neurodegeneration
Figueiredo‐Pereira, M. E., Corwin, C., & Babich, J. W. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12987 · Cited by 42
Tallon, C., Picciolini, S., Yoo, S., Thomas, A. G., Pal, A., Alt, J., Carlomagno, C., Gualerzi, A., Rais, R., Haughey, N. J., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114796 · Cited by 41
Yang, S., Magnutzki, A., Alami, N. O., Lattke, M., Hein, T. M., Scheller, J. S., Kröger, C., Oswald, F., Yilmazer‐Hanke, D., Wirth, T., et al. (2021) · Cells · doi:10.3390/cells10102669 · Cited by 42
Tumor Innervation: History, Methodologies, and Significance
Baraldi, J. H., Martyn, G. V., Shurin, G. V., & Shurin, M. R. (2022) · Cancers · doi:10.3390/cancers14081979 · Cited by 41
Blood Leukocyte Counts in Alzheimer Disease
Luo, J. M., Thomassen, J. Q., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Frikke‐Schmidt, R. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.35648 · Cited by 42
Cui, J., Xiao, S., Cao, Y., Zhang, Y., Yang, J., Zheng, L., Zhao, F., Liu, X., Liu, D., Zhou, Z., et al. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c07427 · Cited by 43
Validating GWAS Variants from Microglial Genes Implicated in Alzheimer’s Disease
dos Santos, L. R., Pimassoni, L. H. S., Sena, G. G. S., Camporez, D., Belcavello, L., Trancozo, M., Morelato, R. L., Errera, F. I. V., Passos‐Bueno, M. R., & Paula, F. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0928-7 · Cited by 42
Inflammation and bone mineral density: A Mendelian randomization study
Huang, J. V., & Schooling, C. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-09080-w · Cited by 42
Wang, D., Hu, M. S., Li, X., Zhang, D., Chen, C., Fu, J., Shao, S., Shi, G., Zhou, Y., Wu, S., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.053 · Cited by 41
Medina‐Ceja, L., Salazar‐Sánchez, J. C., Ortega‐Ibarra, J., & Morales‐Villagrán, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235976 · Cited by 41
The Role of Microglia in Perioperative Neurocognitive Disorders
Fan, W., Mai, L., Zhu, X. M., Huang, F., & He, H. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00261 · Cited by 42
Plasma Biomarkers of Alzheimer’s Disease in African Americans
Deniz, K., Ho, C. C. G., Malphrus, K. G., Reddy, J. S., Nguyen, T., Carnwath, T., Crook, J. E., Lucas, J. A., Graff‐Radford, N. R., Carrasquillo, M. M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200828 · Cited by 42
Tajbakhsh, A., Read, M. I., Barreto, G. E., Ávila-Rodriguez, M., Hayat, S. M. G., & Sahebkar, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173873 · Cited by 41
Stem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling
Si, Z., & Wang, X. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000324 · Cited by 42
CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer’s disease
Crivelli, S. M., Luo, Q., Stevens, J., Giovagnoni, C., van Kruining, D., Bode, G. H., den Hoedt, S., Hobo, B., Scheithauer, A.-L., Walter, J., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00780-0 · Cited by 41
Stefanova, N. A., Ershov, N. I., & Kolosova, N. G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3984906 · Cited by 40
Kim, S., Sharma, C., Jung, U. J., & Kim, S. R. (2023) · Biomedicines · doi:10.3390/biomedicines11051383 · Cited by 40
SELENOK-dependent CD36 palmitoylation regulates microglial functions and Aβ phagocytosis
Ouyang, P., Cai, Z., Peng, J., Lin, S., Chen, X., Chen, C., Feng, Z., Wang, L., Song, G.-L., & Zhang, Z. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103064 · Cited by 40
Feng, X., Jiang, B., Zhai, S.-N., Liu, C., Wu, H., Zhu, B.-Q., Wei, M.-Y., Wei, J., Yang, L. C., & Chen, L. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02624-w · Cited by 40
Fas apoptosis inhibitory molecules: more than death‐receptor antagonists in the nervous system
Planells‐Ferrer, L., Urresti, J., Coccia, E., Galenkamp, K. M. O., Calleja‐Yagüe, I., López‐Soriano, J., Carriba, P., Barneda‐Zahonero, B., Segura, M. F., & Comella, J. X. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13729 · Cited by 40
Karamanova, N., Truran, S., Serrano, G. E., Beach, T. G., Madine, J., Weissig, V., Davies, H. A., Veldhuizen, J., Nikkhah, M., Hansen, M., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014810 · Cited by 40
A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease
Yang, A., Liu, C., Wu, J., Kou, X., & Shen, R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173950 · Cited by 41
Effects of vitamin E on neurodegenerative diseases: an update
İçer, M. A., Arslan, N., & Karadağ, M. G. (2021) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2021-003 · Cited by 44
The Emerging Role of Circular RNAs in Alzheimer’s Disease and Parkinson’s Disease
Zhang, M., & Bian, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.691512 · Cited by 44
Tisdall, M. D., Ohm, D. T., Lobrovich, R., Das, S. R., Mizsei, G., Prabhakaran, K., Ittyerah, R., Lim, S., McMillan, C. T., Wolk, D. A., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102913 · Cited by 41
Kanjhan, R., Noakes, P. G., & Bellingham, M. C. (2015) · Neural Plasticity · doi:10.1155/2016/3423267 · Cited by 42
Jiang, X., Zhou, J., Wang, Y., Chen, L., Duan, Y., Huang, J., Liu, C., Chen, Y., Liu, W., Sun, H., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112751 · Cited by 39
New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease
Penke, B., Szűcs, M., & Bogár, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065383 · Cited by 39
Crivelli, S. M., Quadri, Z., Vekaria, H. J., Zhu, Z., Tripathi, P., Elsherbini, A. M., Zhang, L., Sullivan, P. G., & Bieberich, E. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01633-7 · Cited by 39
Monocyte-derived macrophages act as reinforcements when microglia fall short in Alzheimer’s disease
Abellanas, M. A., Purnapatre, M., Burgaletto, C., & Schwartz, M. (2025) · Nature Neuroscience · doi:10.1038/s41593-024-01847-5 · Cited by 40
Immunotherapies in Alzheimer’s disease: Too much, too little, too late or off-target?
St‐Amour, I., Cicchetti, F., & Calon, F. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1518-9 · Cited by 40
Personalized genetics of the cholinergic blockade of neuroinflammation
Simchovitz, A., Heneka, M. T., & Soreq, H. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13928 · Cited by 39
Chuang, K., Li, M., Lin, N., Chang, C.-H., Lu, I.-H., Pan, I.-H., Takahashi, T., Perng, M., & Wen, S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5414297 · Cited by 40
Recent Advances: Decoding Alzheimer’s Disease With Stem Cells
Fang, Y., Gao, T., Zhang, B., & Pu, J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00077 · Cited by 39
Gabin, J. M., Saltvedt, I. T., Tambs, K., & Holmen, J. (2018) · Immunity & Ageing · doi:10.1186/s12979-017-0106-3 · Cited by 39
Eede, P., Obst, J., Benke, E., Yvon‐Durocher, G., Richard, B. C., Gimber, N., Schmoranzer, J., Böddrich, A., Wanker, E. E., Prokop, S., et al. (2020) · EMBO Reports · doi:10.15252/embr.201948530 · Cited by 39
Self-citationMib2 Deficiency Inhibits Microglial Activation and Alleviates Ischemia-Induced Brain Injury
Li, X., Liao, Y., Dong, Y., Li, S., Wang, F., Wu, R., Yuan, Z., & Cheng, J. (2020) · Aging and Disease · doi:10.14336/ad.2019.0807 · Cited by 39
Characterization by Nano-Infrared Spectroscopy of Individual Aggregated Species of Amyloid Proteins
Waeytens, J., Hemelryck, V. V., Deniset‐Besseau, A., Ruysschaert, J., Dazzi, A., & Raussens, V. (2020) · Molecules · doi:10.3390/molecules25122899 · Cited by 41
Cerebral sterile inflammation in neurodegenerative diseases
Otani, K., & Shichita, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00137-4 · Cited by 39
Vitali, R., Prioreschi, C., Lorenzo-Rebenaque, L., Colantoni, E., Giovannini, D., Frusciante, S., Diretto, G., Marco‐Jiménez, F., Mancuso, M., Casciati, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911495 · Cited by 43
Hooshmand, M. J., Nguyen, H. X., Piltti, K. M., Benavente, F., Hong, S., Flanagan, L. A., Uchida, N., Cummings, B. J., & Anderson, A. J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600064 · Cited by 39
Synapses, Microglia, and Lipids in Alzheimer’s Disease
Paasila, P. J., Aramideh, J. A., Sutherland, G. T., & Graeber, M. B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.778822 · Cited by 40
Cellular transcriptional alterations of peripheral blood in Alzheimer’s disease
Song, L., Yang, Y., Guo, Q., & Zhao, X. (2022) · BMC Medicine · doi:10.1186/s12916-022-02472-4 · Cited by 40
Xia, X., He, X., Zhao, T., Yang, J., Bi, Z., Fu, Q., Liu, J., Ao, D., Wei, Y., & Wei, X. (2023) · Cell Proliferation · doi:10.1111/cpr.13529 · Cited by 38
Falcão, A. S., Carvalho, L. A. R., Lidónio, G. M. D. C., Vaz, A. R., Lucas, S. D., Moreira, R., & Brites, D. M. T. O. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00250 · Cited by 38
Tong, L., Prieto, G. A., & Cotman, C. W. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1158-9 · Cited by 38
Purinergic signaling in Alzheimer’s disease
Erb, L., Woods, L. T., Khalafalla, M. G., & Weisman, G. A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.014 · Cited by 39
Kaushik, R., Morkovin, E. I., Schneeberg, J., Confettura, A. D., Kreutz, M. R., Senkov, O., & Dityatev, A. E. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00411 · Cited by 38
Pharmacological Interventions to Attenuate Alzheimer’s Disease Progression: The Story So Far
Bazzari, F. H., Abdallah, D. M., & El-Abhar, H. S. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190301111120 · Cited by 39
Liu, P., Zhao, B., Wei, M., Li, Y., Liu, J., Ma, L., Shang, S., Huo, K., Wang, J., Li, R., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191317 · Cited by 40
Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases
Baidya, F., Bohra, M., Datta, A., Sarmah, D., Shah, B., Jagtap, P., Raut, S., Sarkar, A., Singh, U., Kalia, K., et al. (2020) · Immunology · doi:10.1111/imm.13264 · Cited by 39
Jiang, X., Wang, Y., Liu, C., Xing, C., Wang, Y., Lyu, W., Wang, S., Li, Q., Chen, T., Chen, Y., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115940 · Cited by 38
Li, F., Hearn, M. T. W., & Bennett, L. E. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1876630 · Cited by 38
Prolactin and Its Altered Action in Alzheimer’s Disease and Parkinson’s Disease
Nguyen, H. D., Yu, B. P., Hoang, N. H. M., Jo, W. H., Chung, H. Y., & Kim, M. (2021) · Neuroendocrinology · doi:10.1159/000517798 · Cited by 38
Nguyen, H. D., Jo, W. H., Hoang, N. H. M., & Kim, M. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108736 · Cited by 38
Coşacak, M. İ., Bhattarai, P., Jager, P. L. D., Menon, V., Tosto, G., & Kızıl, Ç. (2022) · Cells · doi:10.3390/cells11111807 · Cited by 39
Khan, K. M., Balasubramanian, N., Gaudencio, G., Wang, R., Selvakumar, G. P., Kolling, L. J., Pierson, S. R., Tadinada, S. M., Abel, T. G., Hefti, M. M., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01546-5 · Cited by 37
Shimojo, M., Higuchi, M., Suhara, T., & Sahara, N. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00482 · Cited by 37
Chen, L., Zhao, X., & Yan, X. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05870 · Cited by 38
Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
Essayan-Perez, S., Zhou, B., Nabet, A. M., Wernig, M., & Huang, Y. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104503 · Cited by 40
Salani, F., Sterbini, V., Sacchinelli, E., Garramone, M., & Bossù, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01768 · Cited by 37
Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
Biber, K., Bhattacharya, A., Campbell, B. M., Piro, J. R., Rohe, M., Staal, R. G. W., Talanian, R. V., & Möller, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00840 · Cited by 39
Qin, C., Hu, S., Zhang, S., Zhao, D., Wang, Y., Li, H., Peng, Y., Shi, L., Xu, X., Wang, C., et al. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000797 · Cited by 39
Ma, T., Wang, F., Xu, S., & Huang, J. H. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.01.028 · Cited by 38
Teitsdottir, U. D., Halldórsson, S., Rolfsson, Ó., Lund, S. H., Jónsdóttir, M. K., Snædal, J., & Petersen, P. H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200964 · Cited by 39
Skok, M. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i8.1072 · Cited by 37
Frigerio, I., Boon, B. D. C., Lin, C., Graaf, Y. G.-D., Bol, J. G. J. M., Preziosa, P., Twisk, J. W. R., Barkhof, F., Hoozemans, J. J. M., Bouwman, F. H., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab281 · Cited by 38
Necroptosis in Alzheimer’s disease: Potential therapeutic target
Richard, R., & Mousa, S. A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113203 · Cited by 37
Mechanistic insights into the role of herpes simplex virus 1 in Alzheimer’s disease
Feng, S., Liu, Y., Zhou, Y., Shu, Z., Cheng, Z., Brenner, C., & Feng, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1245904 · Cited by 36
Hansson, E., & Skiöldebrand, E. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0091-2 · Cited by 36
Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET
Barron, A. M., Tokunaga, M., Zhang, M., Ji, B., Suhara, T., & Higuchi, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0700-x · Cited by 37
Vargas-Restrepo, F., Sabogal-Guáqueta, A. M., & Cardona‐Gómez, G. P. (2017) · Biomédica · doi:10.7705/biomedica.v38i0.3761 · Cited by 36
Mechanistic Effect of Heavy Metals in Neurological Disorder and Brain Cancer
Agnihotri, S. K., & Kesari, K. K. (2019) · Environmental science and engineering · doi:10.1007/978-3-319-96511-6_2 · Cited by 39
Thibeau, S., McDermott, K. L., McFall, G. P., Rockwood, K. J., & Dixon, R. A. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0509-9 · Cited by 36
Oxylipin Profiling of Alzheimer’s Disease in Nondiabetic and Type 2 Diabetic Elderly
Morris, J. K., Piccolo, B. D., John, C. S., Green, Z. D., Thyfault, J. P., & Adams, S. H. (2019) · Metabolites · doi:10.3390/metabo9090177 · Cited by 36
Микроглия в гомеостазе центральной нервной системы и нейровоспалении
Gogoleva, V. S., Друцкая, М. С., & Атретханы, К.-С. Н. (2019) · Molecular Biology · doi:10.1134/s0026898419050057 · Cited by 36
Mroueh, M., Faour, W. H., Shebaby, W. N., Daher, C. F., Ibrahim, T. M., & Ragab, H. M. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103895 · Cited by 37
Heo, Y., Kim, K., Kim, J., Jang, J., & Park, C. B. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c02349 · Cited by 36
Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease
Kang, Y. J., Diep, Y. N., Tran, M., & Cho, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249591 · Cited by 36
Yanguas‐Casás, N., Torres‐Fuentes, C., Crespo‐Castrillo, A., Díaz-Pacheco, S., Healy, K., Stanton, C., Chowen, J. A., García‐Segura, L. M., Arévalo, M., Cryan, J. F., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105495 · Cited by 36
Zhang, S., Wei, D., Lv, S., Wang, L., An, H., Shao, W., Wang, Y., Huang, Y., Peng, D., & Zhang, Z. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220532 · Cited by 36
Nam, K. N., Mounier, A., Fitz, N. F., Wolfe, C. M., Schug, J., Lefterov, I. M., & Koldamova, R. P. (2016) · Scientific Reports · doi:10.1038/srep24048 · Cited by 36
Complex role of chemokine mediators in animal models of Alzheimer's Disease
Martin, E., & Delarasse, C. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.01.002 · Cited by 40
Lipid metabolism transcriptomics of murine microglia in Alzheimer’s disease and neuroinflammation
Shippy, D. C., & Ulland, T. K. (2023) · Scientific Reports · doi:10.1038/s41598-023-41897-6 · Cited by 35
Senescent accelerated prone 8 (SAMP8) mice as a model of age dependent neuroinflammation
Fernández, A., Quintana, E., Velasco, P., Moreno-Jimenez, B., de Andrés, B., Gaspar, M.-L., Liste, I., Vilar, M., Mira, H., & Cano, E. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02104-3 · Cited by 38
Cerdeira, C. D., & Brigagão, M. R. P. L. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2367682 · Cited by 36
Roy, N., Haq, I., Ngo, J. C., Bennett, D. A., Teich, A. F., Jager, P. L. D., Olah, M., & Sher, F. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02835-6 · Cited by 38
Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging
Coder, B., Wang, W., Wang, L., Wu, Z., Zhuge, Q., & Su, D. (2016) · Oncotarget · doi:10.18632/oncotarget.12572 · Cited by 36
Liu, Y., Xu, Y., Zhang, L., Huang, L., Yü, P., Zhu, H., Deng, W., & Qin, C. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12706 · Cited by 35
Why microglia kill neurons after neural disorders? The friendly fire hypothesis
Gomes‐Leal, W. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.255359 · Cited by 37
Novel functions of inactive rhomboid proteins in immunity and disease
Geesala, R., Issuree, P. D. A., & Maretzky, T. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3vmr0219-069r · Cited by 35
Moore, A. M., Mahoney, E. R., Dumitrescu, L. C., Jager, P. L. D., Koran, M. E. I., Petyuk, V., Robinson, R. A. S., Ruderfer, D. M., Cox, N. J., Schneider, J. A., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.021 · Cited by 38
Association Between Psoriasis and Dementia: Current Evidence
Liu, L., Chen, S., Li, H., Qiang, Y., Sun, X., Zhou, Y., Xing, M., Luo, Y., Ru, Y., Ding, X., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.570992 · Cited by 35
Modeling regulatory network topology improves genome-wide analyses of complex human traits
Zhu, X., Duren, Z., & Wong, W. H. (2021) · Nature Communications · doi:10.1038/s41467-021-22588-0 · Cited by 36
Liu, S., Yuan, X., Su, H., Liu, F., Zhuang, Z., & Chen, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.892368 · Cited by 35
Yang, J., Wang, X., Liu, J., Chi, W., Zhang, L., Xiao, L., & Yan, J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04042 · Cited by 35
Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration
Kunze, R., Fischer, S., Marti, H. H., & Preissner, K. T. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00954-y · Cited by 37
Banerjee, P., Sahoo, A., Anand, S., Bir, A., & Chakrabarti, S. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150514 · Cited by 37
Speidell, A. P., Demby, T. C., Lee, Y., Rodriguez, O. C., Albanese, C., Mandelblatt, J. S., & Rebeck, G. W. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9954-7 · Cited by 36
Metadata
- Authors
- Heppner, F. L., Ransohoff, R. M., & Becher, B.
- Affiliations
- NeuroCure Cluster of Excellence (DE)
- Biogen (United States) (US)
- University of Zurich (CH)
- Corresponding author
- Heppner, Frank L.
- Ransohoff, Richard M.
- Becher, Burkhard
- Venue
- Nature Reviews Neuroscience
- Published
- 2015-05-20
- Volume
- 16
- Issue
- 6
- Pages
- 358-372
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W1841850981
- Cited by
- 2,134
- References
- 220
- Citations by year
- 2026: 121 · 2025: 157 · 2024: 166 · 2023: 173 · 2022: 211 · 2021: 264 · 2020: 221 · 2019: 192 · 2018: 225 · 2017: 205 · 2016: 153 · 2015: 43
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, neuroinflammation, innate immunity, microglia, cytokines, amyloid hypothesis, pathogenesis, therapeutic target
- MeSH terms
- Alzheimer Disease, Animals, Humans, Inflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review